Shankar M Bakkannavar

Dr. Shankar M Bakkannavar

Department of Forensic Medicine & Toxicology, Kasturba Medical College, Manipal, Mahe University, Manipal, Karnataka 576104, India
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
GCGbd 2019 Snakebite Envenomation Collaborators
Gbd 2019 Snakebite Envenomation Collaborators
NRNicholas L. S. Roberts
Nicholas L. S. Roberts
EJEmily K. Johnson
Emily K. Johnson
SZScott M. Zeng
Scott M. Zeng
EHErin B. Hamilton
Erin B. Hamilton
KOKanyin Liane Ong
Kanyin Liane Ong
Snakebite envenoming is an important cause of preventable death. The World Health Organization (WHO) set a goal to halve snakebite mortality by 2030. We used verbal autopsy and vital registration data to model the proportion of venomous animal deaths due to snakes by location, age, year, and sex, and applied these proportions to venomous animal contact mortality estimates from the Global Burden of Disease 2019 study. In 2019, 63,400 people (95% uncertainty interval 38,900–78,600) died globally from snakebites, which was equal to an age-standardized mortality rate (ASMR) of 0.8 deaths (0.5–1.0) per 100,000 and represents a 36% (2–49) decrease in ASMR since 1990. India had the greatest number of deaths in 2019, equal to an ASMR of 4.0 per 100,000 (2.3—5.0). We forecast mortality will continue to decline, but not sufficiently to meet WHO’s goals. Improved data collection should be prioritized to help target interventions, improve burden estimation, and monitor progress.

1 November 2012 in Journal of Forensic and Legal Medicine
Verified
Journal Article
Closed access
TKTanuj Kanchan
Tanuj Kanchan
VKVaman Kulkarni
Vaman Kulkarni
SBShankar M Bakkannavar
Shankar M Bakkannavar
NKNithin Kumar
Nithin Kumar
BUB. Unnikrishnan
B. Unnikrishnan

1 January 2015 in Toxicology International
Verified
Journal Article
Open access
SBShankar M Bakkannavar
Shankar M Bakkannavar
TKTanuj Kanchan
Tanuj Kanchan
PAPreethamR Acharya
PreethamR Acharya
Morbidity and mortality related to acute poisoning is a serious health concern worldwide. Paraquat is known to be responsible for a number of acute poisonings in south India. The study aims at presenting the various aspects of paraquat poisoning that include patient profile, clinical presentation, end-organ complications, and observations at autopsy. The present registry-based retrospective research was conducted in a tertiary care teaching hospital in south India. All the confirmed cases of paraquat poisoning were included in the present study. The postmortem and hospital records of these patients were retrieved and relevant information was collected and analyzed. Paraquat poisonings constituted 14.4% of the total poisoning fatalities during the study period. Equal number of males and females were observed in the present study. The victims were aged between 17 and 65 years (mean ± SD = 30.2 ± 13.1 years). Manner of death was suicidal in 92.9% cases. Common presenting symptoms after ingestion of paraquat included vomiting, followed by difficulty in breathing. In the present series, overall survival post paraquat consumption ranged between 10 h and 25 days. Half of the victims died within 2 days of consumption of poison. The underlying cause of death included acute renal failure (ARF), adult respiratory distress syndrome (ARDS), multiorgan failure (MOF), acute liver failure, etc., In all the cases, brain was congested and edematous, and visceral organs showed marked congestion at autopsy. Lungs were congested with marked edema in 10 cases. It is recommended that the availability of this highly toxic substance be restricted so as to prevent its misuse as a method of suicide.

1 August 2010 in Journal of Forensic and Legal Medicine
Verified
Journal Article
Closed access
TKTanuj Kanchan
Tanuj Kanchan
RMRitesh G. Menezes
Ritesh G. Menezes
TKT.S. Mohan Kumar
T.S. Mohan Kumar
SBShankar M Bakkannavar
Shankar M Bakkannavar
MBMario Joseph Bukelo
Mario Joseph Bukelo
BSB. Suresh Kumar Shetty
B. Suresh Kumar Shetty

23 March 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
DRDivya Ramesh
Divya Ramesh
SBShankar M Bakkannavar
Shankar M Bakkannavar
VBVinutha R Bhat
Vinutha R Bhat
KSKrishna Sharan
Krishna Sharan
Extracellular vesicles (EVs) are lipid-bound vesicles produced into the extracellular space by cells. Apoptotic bodies (ApoBD), microvesicles (MVs), and exosomes are examples of EVs, which act as essential regulators in cell-cell communication in both normal and diseased conditions. Natural cargo molecules such as miRNA, messenger RNA, and proteins are carried by EVs and transferred to nearby cells or distant cells through the process of circulation. Different signalling cascades are then influenced by these functionally active molecules. The information to be delivered to the target cells depends on the substances within the EVs that also includes synthesis method. EVs have attracted interest as potential delivery vehicles for therapies due to their features such as improved circulation stability, biocompatibility, reduced immunogenicity, and toxicity. Therefore, EVs are being regarded as potent carriers of therapeutics that can be used as a therapeutic agent for diseases like cancer. This review focuses on the exosome-mediated drug delivery to cancer cells and the advantages and challenges of using exosomes as a carrier molecule.

1 November 2009 in Journal of Forensic and Legal Medicine
Verified
Journal Article
Closed access
TKT.S. Mohan Kumar
T.S. Mohan Kumar
FMFrancis N.P. Monteiro
Francis N.P. Monteiro
PBPrashantha Bhagavath
Prashantha Bhagavath
SBShankar M Bakkannavar
Shankar M Bakkannavar